Bone Metastasis and Molecular Mechanisms: Pathophysiology (Cancer Metastasis - Biology and Treatment, 6)

Patients with advanced breast or prostate cancers usually develop bone metastases. The principal complications resulting from metastatic bone disease are pain, spinal cord compression, pathologic fractures and bone marrow suppression. Improving the management of bone metastases is crucial to quality of life for patients with breast and prostate cancer. Advances in understanding of the molecular mechanisms underlying the pathophysiology of bone metastasis are driving the development of new therapeutic strategies. The book provides an overview of molecular factors that offer targets and avenues for therapeutic strategies. Being diagnosed with cancer is devastating. But when the cancer cells have to spread to form secondary colonies, the prognosis for the patient is worse. If meaningful improvements in survival are to occur, then control of metastasis will be a foundation. Relatively little is known about the control of the metastatic process at the molecular level. This volume begins to explore our current knowledge regarding the underlying molecular and biochemical mechanisms controlling the metastatic phenotype. While all of the authors attempted to put their findings into a context for translation to the clinical situation, the state-of-the-art does not fully allow this. Nonetheless, we write these summaries of our work as an early effort toward that end. I am grateful to all of the authors who have contributed generously of their time and energies to make this volume a reality. To metastasize, neoplastic cells dissociate from the primary tumor, enter a circulatory compartment (typically lymphatics or blood vasculature), survive transport, arrest, exit the circulation and finally proliferate at a discontinuous site in response to local growth factors. Unless cells accomplish every step of the metastatic cascade, metastases cannot develop. The process is highly inefficient, i. e., about the involvement of signaling Transforming growth factor in tumor development and metastasis. plays a central role in the signaling network that controls morphogenesis, 2. THE BASICS OF growth and cell differentiation in SIGNALING multicellular organisms. The different members of this pleiotropic family of 2. 1. receptor signaling growth and differentiation factors seem to The family of growth factors regulate many processes in human disease consists of more than thirty members in and, in particular, tumor development. humans alone (15, 16). They cluster in Our understanding of how two major groups, the group composed of initiated signals are mediated has both the bone morphogenetic proteins increased dramatically in the last fifteen (BMP) and growth and differentiation years. Firstly, the prototype of factors (GDFs), and the group formed by this still constantly growing family, was the Activins, and Nodals. The two identified and cloned (1). Secondly, the groups differ in their use of receptors for family receptors were transmembrane receptors and the identified by expression cloning from subsequent activation of the mammalian tissue culture (2-7). Thirdly, transcriptional mediators (for recent genetic screens in Drosophila reviews see (13, 14, 17)). Front Matter....Pages i-xvi Models of Breast Cancer Metastasis to Bone: Characterization of a Clinically Relevant Model....Pages 1-18 Quantitation of Bone Metastasis in Experimental Systems....Pages 19-30 Comparative Morphometric Study on Bone Remodeling in Human Specimens and in Experimental Models of Metastatic Bone Disease....Pages 31-48 Clinical Modalities for the Diagnosis, Characterization and Detection of Bone Metastases....Pages 49-69 Metastasis in the Bone Marrow Microenvironment....Pages 71-85 The Role of Tumor-Associated Macrophages in Metastasis-Associated Osteolysis....Pages 87-108 The Malignant Hierarchy in Multiple Myeloma: Relationships between Malignant Cells and Bone Disease....Pages 109-138 Angiogenesis and Lymphangiogenesis in Metastatic Bone Disease: A Matter of Networking....Pages 139-162 Prostate Cancer: Models for Developing Novel Therapeutic Approaches....Pages 163-186 Potential Therapeutic Targets for Bone Metastasis....Pages 187-210 OPG, RANK and RANKL in Bone Metastasis and Cancer-Associated Osteolysis....Pages 211-240 Role of Matrix Metalloproteinases in Bone Metastasis from Human Breast and Prostate Cancer....Pages 241-276 The Role of Bisphosphonates in Bone Metastasis....Pages 277-301 Back Matter....Pages 303-308 Ch. 1. Metastatic Cascade, Molecular/cellular Events And New Therapeutic Opportunities -- Ch. 2. The Role Of Integrin-mediated Processes In The Biology Of Metastasis -- Ch. 3. The Role Of Hyaluronan And Its Degradation Products In Tumour Angiogenesis And Metastasis -- Ch. 4. The E-cadherin/catenin Complex In Invasion: The Role Of Ectodomain Shedding -- Ch. 5. Cancer And Cancer Metastasis-related Genes -- Ch. 6. Hepatocyte Growth Factor And Met In Tumour Invasion-metastasis: From Mechanisms To Cancer Prevention -- Ch. 7. Tight Junctions, A Critical Structure In The Control Of Cancer Invasion And Metastasis -- Ch. 8. Bone Marrow Micrometastases Detection And Significance -- Ch. 9. Polyunsaturated Fatty Acids And Their Role In Cancer Invasion And Metastasis -- Ch. 10. Metastatic Endocrine Cancer -- Ch. 11. Prostate Cancer -- Ch. 12. Gastrointestinal Tumours: Cancer Metastasis, Molecular And Cellular Biology -- Ch. 13. Breast Cancer Metastasis -- Ch. 14. The Malignant Lymphomas -- Ch. 15. Cancer Metastasis: Biological And Clinical Aspects, Gynaecological Cancer. Edited By Wen G. Jiang, Robert E. Mansel. Includes Bibliographical References And Index. Includes Bibliographical References And Index.

Distant metastases are the main cause of cancer-related death. The onset of the metastatic process can now be assessed in cancer patients by the use of immunocyhemical and molecular methods that allow the identification of disseminated carcinoma cells in regional lymph nodes, peripheral blood or distant organs. There is increasing evidence that the detection and characterization of tumor cells present in bone marrow or peripheral blood can provide clinically important information.
In this book, leading experts in the area of micrometastasis research provide an overview that summarizes the current state of research on micrometastatic disease in patients with solid tumors. In each chapter, the technical aspect as well as clinical relevance of micrometastasis detection is discussed.
The book addresses basic researchers as well as clinicians involved in the treatment of cancer patients.

Distant metastases are the main cause of cancer-related death. The onset of the metastatic process can now be assessed in cancer patients by the use of immunocytochemical and molecular methods that allow the identification of disseminated carcinoma cells in regional lymph nodes, peripheral blood or distant organs. There is increasing evidence that the detection and characterization of tumor cells present in bone marrow or peripheral blood can provide clinically important information. In this book, leading experts in the area of micrometastasis research provide an overview that summarizes the current state of research on micrometastatic disease in patients with solid tumors. In each chapter, the technical aspect as well as clinical relevance of micrometastasis detection is discussed. The book addresses basic researchers as well as clinicians involved in the treatment of cancer patients. In recent years, serine proteases and matrix metalloproteinases (MMPs) have gained considerable attention in tumor biology. For most of these proteases, their expression is a reliable indication of ongoing tissue remodeling. This book provides a comprehensive evaluation of the mechanisms of action of proteases and their inhibitors in tumor biology. The first part provides the reader with a selective overview of the molecular biology of serine proteases, MMPs and their physiological inhibitors. The most important proteases and their physiological as well as synthetic inhibitors are evaluated in the most relevant models of experimental and human cancer. The clinical aspects are also taken into account. This volume offers an update on this challenging aspect of cancer treatment, its interest bias, and possible clinical implication. Written by experts worldwide, this book provides the current knowledge of growth factors and their receptors in cancer metastasis. It covers basic cellular and molecular biology of growth factors and their receptors, as well as their role in cancer and cancer metastasis in clinical settings. The book is intended for cancer biologists, cell biologists, biochemists, geneticists, oncologists, surgeons and physicians. It is also a valuable reference for those who work in the area of cancer research, cancer therapies, cancer care, pharmaceutical industry. Postgraduates and undergraduates who pursue a research career in cancer and growth factors will find it an extremely useful reference book "This volume is the first attempt to summarize current knowledge about the underlying molecular and biochemical mechanisms controlling the metastatic phenotype. While all previous authors attempted to put their findings into a context for translation to the clinical situation, the state of the art does not fully allow this because the field of metastasis is relatively new. Nonetheless, the contents of this volume will be of use to members of the cancer research community and clinicians interested in developing and implementing novel forms of treatment for cancer."--Publisher

these Twelve Papers Evaluate The Mechanisms Of Action Of Proteases And Their Inhibitors In Tumor Biology. Beginning With A Selective Overview Of The Relevant Molecular Biology, The Book Evaluates The Physiological And Synthetic Inhibitors In The Various Models Of Experimental And Human Cancer. Specific Chapters Discuss Serine Proteases, Gelatinases, Membrane-type Matrix Metalloproteinases, Drug Design, Clinical Aspects, Tumor-stroma Interactions, And Mammalian Heparanase. Annotation ©2003 Book News, Inc., Portland, Or

Patients with advanced breast or prostate cancers usually develop bone metastases. The principal complications resulting from metastatic bone disease are pain, spinal cord compression, pathologic fractures and bone marrow suppression. Improving the management of bone metastases is crucial to quality of life for patients with breast and prostate cancer.

Advances in understanding of the molecular mechanisms underlying the pathophysiology of bone metastasis are driving the development of new therapeutic strategies.

This book covers the molecular and cellular aspects of cancer metastasis, and discusses the clinical aspect of micro- and macro-metastases, which result in the death of the majority of patients with cancer. The current edition attempts to examine the current status of the basic scientific and clinical research in the area, and is a very useful reference for clinicians, oncologists, and biologists. It is intended for undergraduates as well as postgraduates in the area of medicine, oncology, and cancer biology. Metastasis, the spread of cancer cells to tissues and organs beyond where the tumour is originated and formation of new tumours (secondaries and tertiaries), is the single event that results in death of most of patients with cancer. Dissemination of solid tumours in the bone marrow or blood stream has been described for a variety of malignancies. Edited By Wen G. Jiang, Kunio Matsumoto, Toshikazu Nakamura. Includes Bibliograhical References And Index. Our ability to detect and successfully treat localized cancers has improved appreciably in recent years. Genetic studies have provided important insights in proteinase biology.